Comera Gets Approval, with Over 98% Redemptions

by | May 13, 2022

Comera gets approved, albeit with whopping 98.4% redemptions. A $60M IPO for PNACU. And the rest of the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

SPAC IPO: Prime Number Acquisition I Corp. (PNACU)

Prime Number Acquisition I Corp. (PNACU) prices $60M IPO. $10.20 cash in trust. Unit = share + 1/2 warrant + 1/8 Right. The SPAC, whose target focus is tech/finance, is led by CEO and Chairman Dongfeng Wang, venture partner at China’s LongLing Capital and the Chief Strategy Officer of Taoping (TAOP). CFO and Director David Friedman is the current CFO of optical sensor company Oyla. 

OTR Approves Merger with Comera Life Sciences; High redemptions

Potential squeeze alert: OTR Acquisition Corp. (OTRA) approved its merger with biotech Comera Life Sciences (CMRA). High redemptions– 10.3M shares redeemed (98.4%). That leaves ~168,000 tradable shares. No PIPE. Risk that the deal may not close given the low capital and high redemptions.

Elsewhere in SPACs

  • Kingswood Acquisition Corp. (KWAC) announces an LOI with Wentworth Management Services, a platform of RIAs/broker dealers. The news comes just ahead of extension vote Wednesday. KWAC seeks a 6 month extension.
  • Lionheart Acquisition Corporation II (LCAP) announced a new $1B committed equity facility with Cantor to buy 3.5M of any redeemed shares “at a per share purchase price at or below the redemption price for the shares.” The FPA would trigger before the closing of LCAP’s proposed business combination with MSP Recovery.
  • Better World Acquisition Corp. (BWAC) adds $500k (~7c / share) to trust, bringing NAV to ~$10.37. Shareholders redeemed 5.6M shares at approximately $10.30 / share.
Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

<a href="https://www.boardroomalpha.com/author/joanna/" target="_self">Joanna Makris</a>

Joanna Makris

Joanna has been analyzing and investing in emerging technologies for over two decades, having led the Technology, Media, and Telecom research at several global investment banks, including Mizuho Securities and Canaccord Genuity. Navigating stock market volatility since it all began in 2000. Banjo player, artist, and frittata-maker.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

SPAC Research & Analysis

SPAClife Gets Better with Two DAs

SPAClife gets better with two deal announcements…in biotech. More fun with short squeezes at SKYH. And all the day’s news in SPACs.

Ciao! Pan Euro EV Charging Network Allego Debuts

Glorified extension cords or SaaS story? With EV charging margins ~20%, the software/cloud angle looks like a stretch without better visibility into long-term profitability and earnings growth

Know Who Drives Return Podcast

Sarcos CEO Ben Wolff on Robotics and SPACs

Ben Wolff, CEO of Sarcos, talks to Boardroom Alpha’s David Drapkin about robots, SPACs, and why investors should be looking at Sarcos as an opportunity to invest.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.